Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Amortization of Deferred Charges (2021 - 2025)

Core Scientific (CORZW) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $6.0 million as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 2320.0% to $6.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Dec 2025, up 223.46% year-over-year, with the annual reading at $6.0 million for FY2025, 63.06% up from the prior year.
  • Amortization of Deferred Charges hit $6.0 million in Q4 2025 for Core Scientific, up from $1.3 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $6.2 million in Q4 2021 to a low of -$270000.0 in Q4 2024.
  • Historically, Amortization of Deferred Charges has averaged $2.0 million across 5 years, with a median of $1.3 million in 2025.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 135.9% in 2024 and later skyrocketed 2320.0% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $6.2 million in 2021, then plummeted by 84.59% to $963000.0 in 2022, then fell by 21.91% to $752000.0 in 2023, then plummeted by 135.9% to -$270000.0 in 2024, then surged by 2320.0% to $6.0 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for CORZW at $6.0 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.